InvestSMART

PharmX Technologies Limited (ASX:PHX)

ALERT: Price-sensitive ASX Announcement for PHX
Current share price for PHX : $0.110 -0.03 (-21.43%)+
Announcement
Release
23 Feb 2026 8:27AM
Price at Release
$0.140
Full Release
download
Summary
PharmX Technologies Limited (ASX: PHX) has entered a multi-year strategic alliance with Sigma Healthcare Limited (ASX: SIG), a major pharmaceutical wholesaler and pharmacy operator in Australia. This partnership establishes PharmX as a core technology partner and preferred EDI service provider for Sigma wholesale and Chemist Warehouse retail operations in Australia and New Zealand. The agreement, which includes options for Sigma to acquire up to 19.9% of PharmX, aims to enhance pharmacy supply chains and support industry growth. PharmX will pay Sigma an establishment fee of approximately $8.7 million. This alliance is expected to increase PharmX's revenue potential, although the exact financial impact remains to be defined. PharmX will remain an independent solutions provider across the ANZ market, with the alliance potentially paving the way for global expansion.
Key Points
  • PharmX enters strategic alliance with Sigma Healthcare
  • PharmX becomes preferred EDI provider for Sigma and Chemist Warehouse
  • Sigma to acquire up to 19.9% of PharmX over the alliance term
  • PharmX pays Sigma an establishment fee of approximately $8.7 million
  • Alliance to enhance pharmacy supply chains and support growth
  • Potential for increased revenue and global expansion for PharmX
  • Remains an independent solutions provider in ANZ market
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.